Altoida AG develops digital biomarkers and cognitive assessments for neurological diagnostics. The company provides a tablet-based, self-administered platform that captures cognitive and functional data, including for the early detection of mild cognitive impairment and Alzheimer’s disease.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered3
Digital Cognitive Diagnostics Platform
Digital cognitive diagnostics with a 10-minute self-administered assessment, capturing motor, speech, AR and cognitive data for earlier detection of MCI and Alzheimer’s disease.
Digital Biomarker Platform for Brain Health
Multimodal platform using augmented reality, sensor fusion and explainable AI to capture digital biomarkers for neurological diagnostics and brain-health assessment.
CNS Research and Clinical Trial Support
Support for clinical trials, optimized screening, treatment monitoring and disease-progression research in collaboration with pharmaceutical and biotech companies.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.